Skip to content

Author

Gergana Galabova

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Transcriptional cyclin-dependent kinases as therapeutic targets in bone metastasizing cancers

The potential of CDK9 inhibition in bone metastases is explored, including effects on both tumor cell survival and RANKL-NF-κB -driven osteoclastogenic bone microenvironment, and how CDK12 and CDK13 may provide complementary or context-dependent therapeutic opportunities are discussed.

T. Kähkönen, Gergana Galabova, M. Thormann et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.